In vitro antitumor activity, intracellular accumulation, and DNA adduct formation of cis-[((1R,2R)-1,2-Cyclohexanediamine-N,N')bis(myristato)] platinum (II) suspended in lipiodol

Japanese Journal of Cancer Research

Volumn 91, Issue 1, 2000, Pages 99-104

  Kishimoto, Shuichi ^a   Miyazawa, Kenji ^a   Fukushima, Shoji ^a   Takeuchi, Yoshikazu ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Cisplatin; Hepatocellular carcinoma; Lipiodol; Sustained release

Indexed keywords

CISPLATIN; IODINATED POPPYSEED OIL; PLATINUM COMPLEX; SM 11355; UNCLASSIFIED DRUG; [(1,2 CYCLOHEXANEDIAMINE N,N')BIS(MYRISTATO)] PLATINUM;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES CELL; CONTROLLED STUDY; CULTURE MEDIUM; DNA ADDUCT; DOSE RESPONSE; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DNA INTERACTION; DRUG RELEASE; DRUG UPTAKE; HEPATOMA CELL; IC 50; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034058787     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00865.x     Document Type: Article

References (16)

1. Minoyama, A., Yoshikawa, M., Ebara, M., Saisho, H., Sugiura, N. and Ohto, M. Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma. J. Gastroenterol., 30, 356-366 (1995).
2. Rougier, P., Munck, J. N., Elias, D., Herait, P., Bongel, C., Gosse, C. and Lasser, P. Intra-arterial hepatic chemotherapy with pirarubicin. Preclinical and clinical studies. Am. J. Clin. Oncol., 13, S1-S4 (1990).
3. Vexler, A. M., Mou, X., Gabizon, A. A. and Gorodetsky, R. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. Int. J. Cancer, 60, 611-615 (1995).
4. Iwai, K., Maeda, H. and Konno, T. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res., 44, 2115-2121 (1984).
5. Konno, T. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer, 66, 1897-1903 (1990).
6. Yamashita, Y., Takahashi, M., Bussaka, H., Fukushima, S., Kawaguchi, T. and Nakano, M. Intraarterial infusion of 5-fluoro-2-deoxyuridine-C8 dissolved in a lymphographic agent in malignant liver tumors. A preliminary report. Cancer, 64, 2437-2444 (1989).
7. Shibata, J., Fujiyama, S., Sato, T., Kishimoto, S., Fukushima, S. and Nakano, M. Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer, 64, 1586-1594 (1989).
8. Bayraktar, Y., Balkanci, F., Kayhan, B., Uzunalimoglu, B., Gokoz, A., Ozihik, Y., Gurakar, A., Van Theil, D. H. and Filat, D. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma. Hepatogastroenterology, 43, 681-687 (1996).
9. Hirashima, N., Sakakibara, K., Itazu, I., Hirai, T., Nemoto, A., Matsuura, H., Kumada, K., Nojiri, O. and Kano, H. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with Lipiodol-transcatheter arterial embolization. Semin. Oncol., 24, S6-91-S6-96 (1997).
10. Konno, T., Maeda, H., Iwai, K., Tashiro, S., Maki, S., Morinaga, T., Mochinaga, M., Hiraoka, T. and Yokoyama, I. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur. J. Cancer Clin. Oncol., 19, 1053-1065 (1983).
11. Konno, T., Kai, Y., Yamashita, R., Nagamitsu, A. and Kimura, M. Targeted chemotherapy for unresectable primary and metastatic liver cancer. Acta Oncol., 33, 133-137 (1994).
12. Seymour, L. W., Olliff, S. P., Poole, C. J., De Takats, P. G., Orme, R., Ferry, D. R., Maeda, H., Konno, T. and Kerr, D. J. A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate)-neocarzinostatin] in the treatment of primary hepatocellular carcinoma. Int. J. Oncol., 12, 1217-1223 (1998).
13. Fukushima, S., Kishimoto, S., Hayashi, Y., Kaneko, M. and Nakano, M. Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (I) - preparation of LPS and its anticancer effect on a rabbit liver cancer model after injection into the hepatic artery. J. Jpn. Soc. Cancer Ther., 23, 2743-2749 (1988).
14. Maeda, M., Uchida, N. A. and Sasaki, T. Liposoluble platinum (II) complexes with antitumor activity. Jpn. J. Cancer Res. (Gann), 77, 523-525 (1986).
15. Kishimoto, S., Fukui, M., Fukushima, S. and Nakano, M. Application of a lipophilic platinum derivative contained in an oily lymphographic agent to intra-hepatic arterial chemotherapy. Reg. Cancer Treat., 1-2, 25-29 (1992).
16. Han, I., Khokhar, A. R. and Perez-Solar, R. Intraliposomal conversion of lipophilic cis-bis-carboxylato-trans-R,R-1,2-diaminocyclohexane-platinum (II) complexes into cis-bisdichloro-trans-R,R-1,2-diaminocyclohexane-platinum (II). Cancer Chemother. Pharmacol., 39, 17-24 (1996).